3SBio first quarter total net revenues increase 24.5 percent to RMB147 health .2M 3SBio Inc. , a leading China-based biotechnology company focused on researching, developing, marketing and manufacturing biopharmaceutical items, today announced its unaudited financial outcomes for the first quarter ended March 31, 2012. First Quarter 2012 Financial Highlights: Total net revenues increased by 24.5 percent over the first quarter of 2011 to RMB147.2 million , in comparison to RMB118.2 million in the 1st quarter of 2011. Working income was RMB35.5 million , in comparison to operating income of RMB25.3 million in the 1st quarter of 2011. Net gain was RMB32.6 million , in comparison to net income of RMB22.2 million in the first quarter of 2011.
Results demonstrated that: 82 % of cardiologists indicated it had been easier to detect an aortic regurgitation with a Littmann Electronic Stethoscope Model 3000 Series compared to the traditional stethoscope. Grade 2 aortic regurgitation murmurs had been missed five times more regularly with the original scope than with a Littmann Electronic Stethoscope Model 3000 Series. Identifying lung sounds: 137 crucial care nurses paid attention to, and had been asked to identify, prerecorded normal and irregular lung noises presented in the current presence of ambient noise.. StethAssist and Cardioscan recordings and related patient notes are stored electronically and will also be sent to colleagues for a second opinion.